Marshall Wace

Marshall Wace’s Crescent Biopharma CBIO Stock Holding History

Marshall Wace’s Portfolio CBIO Stock Details CBIO Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$520K	Buy
2024 Q2	–	Sell
2024 Q1	$653K	Buy
2023 Q4	$30.4K	Buy
2023 Q3	–	Sell
2023 Q2	$248K	Sell
2023 Q1	$273K	Buy
2022 Q4	$633K	Buy
2019 Q1	–	Sell
2018 Q4	$1.5M	Buy